TABLE OF CONTENTS
Volume 17, Issue 1 (January 2003)
Reviews |
Commentary |
Original Manuscripts |
Molecular Targets for Therapy (MTT) |
Debate Round Table |
Bio-Technical Methods Section (BTS) |
Tools |
Correspondence
Leading Article
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia FREE
J-M Luo, H Yoshida, S Komura, N Ohishi, L Pan, K Shigeno, I Hanamura, K Miura, S Iida, R Ueda, T Naoe, Y Akao, R Ohno and K Ohnishi
Leukemia 17: 1-8; doi:10.1038/sj.leu.2402725
Reviews
New mechanisms of AML1 gene alteration in hematological malignancies FREE
C Roumier, P Fenaux, M Lafage, M Imbert, V Eclache and C Preudhomme
Leukemia 17: 9-16; doi:10.1038/sj.leu.2402766
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia FREE
W J E Tissing, J P P Meijerink, M L den Boer and R Pieters
Leukemia 17: 17-25; doi:10.1038/sj.leu.2402733
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo FREE
F Mortreux, A-S Gabet and E Wattel
Leukemia 17: 26-38; doi:10.1038/sj.leu.2402777
Commentary
High numbers of mobilized stem cells in patients with acute myeloid leukemia in first complete remission: good or bad? FREE
T de Witte
Leukemia 17: 39-40; doi:10.1038/sj.leu.2402796
Original Manuscripts
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo FREE
S Lentzsch, R LeBlanc, K Podar, F Davies, B Lin, T Hideshima, L Catley, D I Stirling and K C Anderson
Leukemia 17: 41-44; doi:10.1038/sj.leu.2402745
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients FREE
F Maloisel, L Benboubker, M Gardembas, B Coiffier, M Divine, C Sebban, M Blanc, J-F Abgrall, P Lederlin, J-L Harousseau, A-M Blaise, B Grosbois, P Morice, C Ghandour and S Castaigne
Leukemia 17: 45-51; doi:10.1038/sj.leu.2402784
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4 FREE
M Broggini, S V Marchini, E Galliera, P Borsotti, G Taraboletti, E Erba, M Sironi, J Jimeno, G T Faircloth, R Giavazzi and M d'Incalci
Leukemia 17: 52-59; doi:10.1038/sj.leu.2402788
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial FREE
S Keating, S Suciu, T de Witte, R Zittoun, F Mandelli, A Belhabri, S Amadori, W Fibbe, E Gallo, G Fillet, B Varet, G Meloni, A Hagemeijer, P Fazi, G Solbu and R Willemze on behalf of the EORTC and GIMEMA Leukemia Groups
Leukemia 17: 60-67; doi:10.1038/sj.leu.2402782
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome FREE
N Feller, G J Schuurhuis, M A van der Pol, G Westra, G W D Weijers, A van Stijn, P C Huijgens and G J Ossenkoppele
Leukemia 17: 68-75; doi:10.1038/sj.leu.2402781
Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells FREE
L Muñoz, J F Nomdedéu, N Villamor, R Guardia, D Colomer, J M Ribera, J P Torres, J J Berlanga, C Fernández, A Llorente, M P Queipo de Llano, J M Sánchez, S Brunet and J Sierra for the Spanish CETLAM Group
Leukemia 17: 76-82; doi:10.1038/sj.leu.2402708
Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia FREE
C H Seedhouse, E P Das-Gupta and N H Russell
Leukemia 17: 83-88; doi:10.1038/sj.leu.2402747
Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study FREE
P Korkolopoulou, N Viniou, N Kavantzas, E Patsouris, I Thymara, P M Pavlopoulos, E Terpos, K Stamatopoulos, E Plata, K Anargyrou, A Androulaki, P Davaris and X Yataganas
Leukemia 17: 89-97; doi:10.1038/sj.leu.2402769
C-fms expression correlates with monocytic differentiation in PML-RAR
+ acute promyelocytic leukemia FREE
R Riccioni, E Saulle, S Militi, N M Sposi, M Gualtiero, N Mauro, M Mancini, D Diverio, F Lo Coco, C Peschle and U Testa
Leukemia 17: 98-113; doi:10.1038/sj.leu.2402812
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA FREE
I Jilani, E Estey, T Manshuri, M Caligiuri, M Keating, F Giles, D Thomas, H Kantarjian and M Albitar
Leukemia 17: 114-119; doi:10.1038/sj.leu.2402743
FLT3 mutations in acute myeloid leukemia cell lines FREE
H Quentmeier, J Reinhardt, M Zaborski and H G Drexler
Leukemia 17: 120-124; doi:10.1038/sj.leu.2402740
Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias FREE
L Cro, A Guffanti, M Colombi, B Cesana, M G Grimoldi, C Patriarca, M Goldaniga, A Neri, D Intini, A Cortelezzi, A T Maiolo and L Baldini
Leukemia 17: 125-132; doi:10.1038/sj.leu.2402737
Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL FREE
C Magnac, R Porcher, F Davi, J Nataf, B Payelle-Brogard, R P Tang, P Oppezzo, V Lévy, G Dighiero and F Ajchenbaum-Cymbalista
Leukemia 17: 133-137; doi:10.1038/sj.leu.2402780
Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia FREE
E Björklund, J Mazur, S Söderhäll and A Porwit-MacDonald
Leukemia 17: 138-148; doi:10.1038/sj.leu.2402736
Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia FREE
S Takeuchi, K Tsukasaki, C R Bartram, T Seriu, M Zimmermann, M Schrappe, N Takeuchi, S Park, H Taguchi and H P Koeffler
Leukemia 17: 149-154; doi:10.1038/sj.leu.2402727
Diphtheria toxin-interleukin-3 fusion protein (DT388IL3) prolongs disease-free survival of leukemic immunocompromised mice FREE
J H Black, J A McCubrey, M C Willingham, J Ramage, D E Hogge and A E Frankel
Leukemia 17: 155-159; doi:10.1038/sj.leu.2402744
Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture FREE
W J C Rombouts and R E Ploemacher
Leukemia 17: 160-170; doi:10.1038/sj.leu.2402763
CD38 expression by hematopoietic stem cells of newborn and juvenile mice FREE
Y Higuchi, H Zeng and M Ogawa
Leukemia 17: 171-174; doi:10.1038/sj.leu.2402785
Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells FREE
T Netelenbos, J van den Born, F L Kessler, S Zweegman, P A Merle, J W van Oostveen, J J Zwaginga, P C Huijgens and A M Dräger
Leukemia 17: 175-184; doi:10.1038/sj.leu.2402738
Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma FREE
S Hermouet, C A Sutton, T M Rose, R J Greenblatt, I Corre, R Garand, A M Neves, R Bataille and J W Casey
Leukemia 17: 185-195; doi:10.1038/sj.leu.2402748
Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma FREE
N Niitsu, Y Honma, K Iijima, T Takagi, M Higashihara, U Sawada and J Okabe-Kado
Leukemia 17: 196-202; doi:10.1038/sj.leu.2402699
Expression and function of chemokine receptors in human multiple myeloma FREE
C Möller, T Strömberg, M Juremalm, K Nilsson and G Nilsson
Leukemia 17: 203-210; doi:10.1038/sj.leu.2402717
Molecular Targets for Therapy (MTT)
Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein FREE
N W C J van de Donk, M M J Kamphuis, M van Dijk, H P E Borst, A C Bloem and H M Lokhorst
Leukemia 17: 211-219; doi:10.1038/sj.leu.2402768
Debate Round Table
Editorial: Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations FREE
Nicole Muller-Bérat, MD, PhD and Prof Thomas Lion, MD, PhD
Leukemia 17: 220; doi:10.1038/sj.leu.2402754
Interference of dye-associated fluorescence signals with quantitative analysis of chimerism by capillary electrophoresis FREE
E Schraml and T Lion
Leukemia 17: 221-223; doi:10.1038/sj.leu.2402755
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience FREE
E Schraml, H Daxberger, F Watzinger and T Lion
Leukemia 17: 224-227; doi:10.1038/sj.leu.2402756
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience FREE
Y Chalandon, S Vischer, C Helg, B Chapuis and E Roosnek
Leukemia 17: 228-231; doi:10.1038/sj.leu.2402758
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience FREE
U Koehl, O Beck, R Esser, E Seifried, T Klingebiel, D Schwabe and C Seidl
Leukemia 17: 232-236; doi:10.1038/sj.leu.2402760
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience FREE
H Kreyenberg, W Hölle, S Möhrle, D Niethammer and P Bader
Leukemia 17: 237-240; doi:10.1038/sj.leu.2402761
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris–Robert Debré experience FREE
C Acquaviva, M Duval, D Mirebeau, R Bertin and H Cavé
Leukemia 17: 241-246; doi:10.1038/sj.leu.2402762
Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR FREE
J P Hancock, N J Goulden, A Oakhill and C G Steward
Leukemia 17: 247-251; doi:10.1038/sj.leu.2402759
Summary: Reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection FREE
T Lion on behalf of the participants of the current round of the Debate
Leukemia 17: 252-254; doi:10.1038/sj.leu.2402753
Bio-Technical Methods Section (BTS)
Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients FREE
A Godon, A Moreau, P Talmant, L Baranger-Papot, F Geneviève, N Milpied, M Zandecki and H Avet-Loiseau
Leukemia 17: 255-259; doi:10.1038/sj.leu.2402739
Tools
IMGT® databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr FREE
M-P Lefranc
Leukemia 17: 260-266; doi:10.1038/sj.leu.2402637
Correspondence
Ubiquinone does not rescue acute myeloid leukemia cells from growth inhibition by statins FREE
L P Burke, L D Lewis and R P Perez
Leukemia 17: 267-268; doi:10.1038/sj.leu.2402695
Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin FREE
J Moppett, V H J van der Velden, A J M Wijkhuijs, J Hancock, J J M van Dongen and N Goulden
Leukemia 17: 268-270; doi:10.1038/sj.leu.2402751
Clinical activity of arsenic trioxide in Burkitt-like lymphoma FREE
F Ravandi and K van Besien
Leukemia 17: 271-272; doi:10.1038/sj.leu.2402735
Zinc modulates c-Myc/Mad1 balance in human leukemia cells FREE
M I Sirinian, S Pisegna, M Paroli, S Militi, U Testa and C Peschle
Leukemia 17: 272-274; doi:10.1038/sj.leu.2402746
